一种用于治疗帕金森病的脑靶向递送的有前景策略：基于环糊精超分子包合物的热敏凝胶

1

J Pharm Anal. 2025 May;15(5):101102. doi: 10.1016/j.jpha.2024.101102. Epub 2024 Sep 13.

2

Colloids Surf B Biointerfaces. 2023 Feb;222:113065. doi: 10.1016/j.colsurfb.2022.113065. Epub 2022 Nov 30.

3

J Drug Target. 2018 Feb;26(2):150-161. doi: 10.1080/1061186X.2017.1350858. Epub 2017 Jul 18.

4

Mater Sci Eng C Mater Biol Appl. 2017 Jul 1;76:966-974. doi: 10.1016/j.msec.2017.03.151. Epub 2017 Mar 18.

5

AAPS PharmSciTech. 2006 Apr 14;7(2):E38. doi: 10.1208/pt070238.

6

Int J Pharm Investig. 2016 Apr-Jun;6(2):78-85. doi: 10.4103/2230-973X.177809.

7

Pak J Pharm Sci. 2022 Sep;35(5):1423-1436.

8

Drug Deliv Transl Res. 2025 Jan 23. doi: 10.1007/s13346-025-01797-w.

9

Polymers (Basel). 2022 Sep 11;14(18):3801. doi: 10.3390/polym14183801.

10

Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr 26. doi: 10.1007/s00210-025-04172-1.

A promising strategy of brain targeted delivery for the treatment of Parkinson's disease: Cyclodextrin supramolecular inclusion complex based thermosensitive gel.